ArticleBMC cancer2019

Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial.

Jeffrey S Hoch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.